|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
DE3572982D1
(en)
|
1984-03-06 |
1989-10-19 |
Takeda Chemical Industries Ltd |
Chemically modified lymphokine and production thereof
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
US5677425A
(en)
|
1987-09-04 |
1997-10-14 |
Celltech Therapeutics Limited |
Recombinant antibody
|
|
GB8809129D0
(en)
|
1988-04-18 |
1988-05-18 |
Celltech Ltd |
Recombinant dna methods vectors and host cells
|
|
EP0401384B1
(en)
|
1988-12-22 |
1996-03-13 |
Kirin-Amgen, Inc. |
Chemically modified granulocyte colony stimulating factor
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
GB9108652D0
(en)
|
1991-04-23 |
1991-06-12 |
Antisoma Ltd |
Immunoreactive compounds
|
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
|
AU4116793A
(en)
|
1992-04-24 |
1993-11-29 |
Board Of Regents, The University Of Texas System |
Recombinant production of immunoglobulin-like domains in prokaryotic cells
|
|
AU686113B2
(en)
|
1992-09-16 |
1998-02-05 |
Scripps Research Institute, The |
Human neutralizing monoclonal antibodies to respiratory syncytial virus
|
|
JP3919830B2
(ja)
|
1992-11-28 |
2007-05-30 |
財団法人化学及血清療法研究所 |
抗ネコヘルペスウイルス−１組換え抗体および該抗体をコードする遺伝子断片
|
|
WO1995018634A1
(en)
|
1994-01-04 |
1995-07-13 |
The Scripps Research Institute |
Human monoclonal antibodies to herpes simplex virus and methods therefor
|
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
EP0983303B1
(en)
|
1997-05-21 |
2006-03-08 |
Biovation Limited |
Method for the production of non-immunogenic proteins
|
|
JP4334141B2
(ja)
|
1998-04-20 |
2009-09-30 |
グリカート バイオテクノロジー アクチェンゲゼルシャフト |
抗体依存性細胞傷害性を改善するための抗体のグリコシル化操作
|
|
GB9814383D0
(en)
|
1998-07-02 |
1998-09-02 |
Cambridge Antibody Tech |
Improvements relating to antibodies
|
|
JP4593783B2
(ja)
|
1998-07-21 |
2010-12-08 |
ゲンマブ・アクティーゼルスカブ |
抗ｃ型肝炎ウイルス抗体およびその使用
|
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
|
EP2275540B1
(en)
|
1999-04-09 |
2016-03-23 |
Kyowa Hakko Kirin Co., Ltd. |
Method for controlling the activity of immunologically functional molecule
|
|
US6818216B2
(en)
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
|
PL213948B1
(pl)
|
2001-10-25 |
2013-05-31 |
Genentech Inc |
Kompozycje zawierajace glikoproteine, czasteczka kwasu nukleinowego kodujaca te glikoproteine, komórka gospodarza, sposób wytwarzania glikoproteiny, kompozycja do zastosowania do leczenia, zastosowanie kompozycji i zestaw zawierajacy kompozycje
|
|
KR20050000380A
(ko)
|
2002-04-09 |
2005-01-03 |
교와 핫꼬 고교 가부시끼가이샤 |
게놈이 개변된 세포
|
|
CA2598454C
(en)
|
2005-02-18 |
2013-04-09 |
Medarex, Inc. |
Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues
|
|
US9212227B2
(en)
|
2012-04-30 |
2015-12-15 |
Janssen Biotech, Inc. |
ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions
|
|
AR091069A1
(es)
*
|
2012-05-18 |
2014-12-30 |
Amgen Inc |
Proteinas de union a antigeno dirigidas contra el receptor st2
|
|
JO3532B1
(ar)
*
|
2013-03-13 |
2020-07-05 |
Regeneron Pharma |
الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها
|
|
SG11201605580RA
(en)
*
|
2014-01-10 |
2016-10-28 |
Anaptysbio Inc |
Antibodies directed against interleukin-33 (il-33)
|
|
GB201403875D0
(en)
*
|
2014-03-05 |
2014-04-16 |
Cantargia Ab |
Novel antibodies and uses thereof
|
|
WO2016122865A1
(en)
*
|
2015-01-30 |
2016-08-04 |
Salk Institute For Biological Studies |
Compositions and methods for treating age-related diabetes and related disorders
|
|
MX387295B
(es)
*
|
2015-03-31 |
2025-03-18 |
Medimmune Ltd |
Nueva forma de interleucina-33 (il33), formas mutadas de interleucina-33 (il33), anticuerpos, ensayos y métodos para usar los mismos.
|
|
SG11201808693WA
(en)
*
|
2016-04-27 |
2018-11-29 |
Pfizer |
Anti-il-33 antibodies, compositions, methods and uses thereof
|
|
CN107446040B
(zh)
*
|
2016-05-30 |
2021-01-12 |
深圳市安群生物工程有限公司 |
人st2抗原表位肽、抗原、抗体、试剂盒及应用
|
|
SG11202104120VA
(en)
*
|
2018-10-31 |
2021-05-28 |
Delinia Inc |
Multivalent regulatory t cell modulators
|
|
CN110357963B
(zh)
*
|
2019-07-31 |
2020-09-18 |
北京智仁美博生物科技有限公司 |
抗人st2抗体及其用途
|
|
US10577424B1
(en)
*
|
2019-08-15 |
2020-03-03 |
Beijing Mabworks Biotech Co., Ltd. |
Antibodies binding VISTA and uses thereof
|
|
CN113214395A
(zh)
*
|
2020-01-21 |
2021-08-06 |
迈威(上海)生物科技股份有限公司 |
抗st2抗体及其应用
|